Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01805804
Recruitment Status : Recruiting
First Posted : March 6, 2013
Last Update Posted : January 4, 2017
Polpharma Pharmaceutical Company
Information provided by (Responsible Party):
Andrzej Tomasik MD PhD FESC, Medical University of Silesia

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : February 2019
Publications automatically indexed to this study by Identifier (NCT Number):